Selective serotonin reuptake inhibitors versus placebo in patients with major depressive disorder. A systematic review with meta-analysis and Trial Sequential Analysis

BACKGROUND: The evidence on selective serotonin reuptake inhibitors (SSRIs) for major depressive disorder is unclear. METHODS: Our objective was to conduct a systematic review assessing the effects of SSRIs versus placebo, ‘active’ placebo, or no intervention in adult participants with major depress...

Descripción completa

Detalles Bibliográficos
Autores principales: Jakobsen, Janus Christian, Katakam, Kiran Kumar, Schou, Anne, Hellmuth, Signe Gade, Stallknecht, Sandra Elkjær, Leth-Møller, Katja, Iversen, Maria, Banke, Marianne Bjørnø, Petersen, Iggiannguaq Juhl, Klingenberg, Sarah Louise, Krogh, Jesper, Ebert, Sebastian Elgaard, Timm, Anne, Lindschou, Jane, Gluud, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5299662/
https://www.ncbi.nlm.nih.gov/pubmed/28178949
http://dx.doi.org/10.1186/s12888-016-1173-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5299662/
https://www.ncbi.nlm.nih.gov/pubmed/28178949
http://dx.doi.org/10.1186/s12888-016-1173-2

Ejemplares similares